US RWE Director, Respiratory Value & Access

AstraZeneca

Wilmington (DE)

Hybrid

USD 180,000 - 260,000

Full time

4 days ago
Be an early applicant
Application generator

Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.

Get past ATS filters

Benefits offered by this job

Office-based 3 days/week
Flexible work arrangements

Job summary

AstraZeneca in Wilmington, DE leads an Executive-level role shaping the clinical and economic value story for inhaled respiratory portfolio. You will design evidence programs and translate them for payers, health systems, and policy makers in a payer-ready framework.

You will partner across Medical, Market Access, Field Medical, and Commercial teams to secure access and inform policy. This role requires strategic thinking, data-driven storytelling, and strong collaboration.

Qualifications

  • 5+ years of RWE experience in pharma or related field.
  • Expertise in observational study design and real-world data sources.
  • Strong understanding of US payer landscape and policy shifts.
  • Proven ability to translate evidence for non-technical US stakeholders.
  • Experience with AMCP dossiers and payer submissions (Desirable).

Responsibilities

  • Lead US value proposition and align evidence to brand strategy.
  • Design and implement Integrated Evidence Plan across outputs.
  • Design and deliver RWE studies and apply bias mitigation.
  • Identify datasets and ensure representativeness and health equity.
  • Contribute to cost-effectiveness and budget impact models.
  • Translate RWE into tools for MSLs and payers.

Skills

Leadership
RWE leadership
Observational studies
Causal inference
US healthcare knowledge
Communication
Cross-functional collaboration

Education

Advanced degree (PhD/MD/PharmD/Master)

Job description

AstraZeneca in Wilmington, DE leads an Executive-level role shaping the clinical and economic value story for inhaled respiratory portfolio. You will design evidence programs and translate them for payers, health systems, and policy makers in a payer-ready framework.

You will partner across Medical, Market Access, Field Medical, and Commercial teams to secure access and inform policy. This role requires strategic thinking, data-driven storytelling, and strong collaboration.

Get your free, confidential resume review.
or drag and drop your file here.
Similar jobs

Similar jobs worth comparing

RWE Strategy Lead, Respiratory Value & Access
RWE Strategy Lead, Respiratory Value & Access

AstraZeneca GmbH • Wilmington (DE)

On-site
USD 170,000 - 250,000
AI-Driven US RWE Director, Respiratory & Immunology
AI-Driven US RWE Director, Respiratory & Immunology

AstraZeneca GmbH • Wilmington (DE)

On-site
USD 200,000 - 320,000
Director, US Market Access (Respiratory Biologics)
Director, US Market Access (Respiratory Biologics)

AstraZeneca • Wilmington (DE)

On-site
USD 194,000 - 291,000
401(k) plan
Health benefits
Paid vacation & holidays
US Brand Insights Director — Respiratory Growth Strategy
US Brand Insights Director — Respiratory Growth Strategy

AstraZeneca • Wilmington (DE)

Hybrid
USD 180,000 - 280,000
RWE Director, Inhaled Portfolio
RWE Director, Inhaled Portfolio

AstraZeneca • Wilmington (DE)

Hybrid
USD 180,000 - 260,000
Office-based 3 days/week
Flexible work arrangements
RWE Director, Inhaled Portfolio
RWE Director, Inhaled Portfolio

AstraZeneca GmbH • Wilmington (DE)

On-site
USD 170,000 - 250,000
Executive Regulatory Leader — Respiratory & Immunology
Executive Regulatory Leader — Respiratory & Immunology

AstraZeneca GmbH • Gaithersburg (MD)

Hybrid
USD 240,000 - 400,000
401(k) retirement plan
Vacation and holidays
Paid leaves
+1
Director, Real-World Evidence & US Access Strategy
Director, Real-World Evidence & US Access Strategy

AstraZeneca GmbH • Wilmington (DE)

Hybrid
USD 180,000 - 240,000
Hybrid work model
Director, Oncology Value Strategy & Access (US)
Director, Oncology Value Strategy & Access (US)

AstraZeneca • Gaithersburg (MD)

On-site
USD 186,000 - 279,000
401(k) plan
Health benefits
US Market Access Director — Early Asset Value Strategy
US Market Access Director — Early Asset Value Strategy

AstraZeneca GmbH • Wilmington (DE)

Hybrid
USD 180,000 - 235,000